GR940300022T1 - Delivery of x-ray contrast agents using receptor mediated endocytosis. - Google Patents
Delivery of x-ray contrast agents using receptor mediated endocytosis.Info
- Publication number
- GR940300022T1 GR940300022T1 GR940300022T GR940300022T GR940300022T1 GR 940300022 T1 GR940300022 T1 GR 940300022T1 GR 940300022 T GR940300022 T GR 940300022T GR 940300022 T GR940300022 T GR 940300022T GR 940300022 T1 GR940300022 T1 GR 940300022T1
- Authority
- GR
- Greece
- Prior art keywords
- delivery
- contrast agents
- ray contrast
- receptor mediated
- mediated endocytosis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0442—Polymeric X-ray contrast-enhancing agent comprising a halogenated group
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/08—Processes
- C08G18/16—Catalysts
- C08G18/18—Catalysts containing secondary or tertiary amines or salts thereof
- C08G18/1808—Catalysts containing secondary or tertiary amines or salts thereof having alkylene polyamine groups
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/08—Processes
- C08G18/16—Catalysts
- C08G18/18—Catalysts containing secondary or tertiary amines or salts thereof
- C08G18/1816—Catalysts containing secondary or tertiary amines or salts thereof having carbocyclic groups
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/08—Processes
- C08G18/16—Catalysts
- C08G18/18—Catalysts containing secondary or tertiary amines or salts thereof
- C08G18/1825—Catalysts containing secondary or tertiary amines or salts thereof having hydroxy or primary amino groups
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/08—Processes
- C08G18/16—Catalysts
- C08G18/18—Catalysts containing secondary or tertiary amines or salts thereof
- C08G18/20—Heterocyclic amines; Salts thereof
- C08G18/2009—Heterocyclic amines; Salts thereof containing one heterocyclic ring
- C08G18/2036—Heterocyclic amines; Salts thereof containing one heterocyclic ring having at least three nitrogen atoms in the ring
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/08—Processes
- C08G18/16—Catalysts
- C08G18/22—Catalysts containing metal compounds
- C08G18/24—Catalysts containing metal compounds of tin
- C08G18/244—Catalysts containing metal compounds of tin tin salts of carboxylic acids
- C08G18/246—Catalysts containing metal compounds of tin tin salts of carboxylic acids containing also tin-carbon bonds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/08—Processes
- C08G18/16—Catalysts
- C08G18/22—Catalysts containing metal compounds
- C08G18/26—Catalysts containing metal compounds of lead
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
- C08J9/04—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent
- C08J9/12—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent by a physical blowing agent
- C08J9/14—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent by a physical blowing agent organic
- C08J9/143—Halogen containing compounds
- C08J9/144—Halogen containing compounds containing carbon, halogen and hydrogen only
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G2101/00—Manufacture of cellular products
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2375/00—Characterised by the use of polyureas or polyurethanes; Derivatives of such polymers
- C08J2375/04—Polyurethanes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Materials Engineering (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Crystallography & Structural Chemistry (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/679,526 US5141739A (en) | 1986-07-03 | 1991-04-02 | Delivery of x-ray contrast agents using receptor mediated endocytosis |
Publications (1)
Publication Number | Publication Date |
---|---|
GR940300022T1 true GR940300022T1 (en) | 1994-04-29 |
Family
ID=24727269
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR940300022T GR940300022T1 (en) | 1991-04-02 | 1994-04-29 | Delivery of x-ray contrast agents using receptor mediated endocytosis. |
Country Status (8)
Country | Link |
---|---|
US (1) | US5141739A (el) |
EP (1) | EP0578765A1 (el) |
JP (1) | JPH06506230A (el) |
CA (1) | CA2105068A1 (el) |
DE (1) | DE578765T1 (el) |
ES (1) | ES2061423T1 (el) |
GR (1) | GR940300022T1 (el) |
WO (1) | WO1992017216A1 (el) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5490991A (en) * | 1986-07-03 | 1996-02-13 | Advanced Magnetics, Inc. | Directed delivery of radioprotectants using a receptor specific carrier |
GB8916782D0 (en) * | 1989-07-21 | 1989-09-06 | Nycomed As | Compositions |
US5236694A (en) * | 1990-02-21 | 1993-08-17 | The Board Of Regents, The University Of Texas System | 19f labelled dextrans and antibodies as nmr imaging and spectroscopy agents |
AU642066B2 (en) * | 1991-01-25 | 1993-10-07 | Nanosystems L.L.C. | X-ray contrast compositions useful in medical imaging |
DE4117782C2 (de) * | 1991-05-28 | 1997-07-17 | Diagnostikforschung Inst | Nanokristalline magnetische Eisenoxid-Partikel, Verfahren zu ihrer Herstellung sowie diagnostische und/oder therapeutische Mittel |
JP2894879B2 (ja) * | 1991-10-04 | 1999-05-24 | 日本メジフィジックス株式会社 | 診断用造影剤 |
US5342605A (en) * | 1992-05-01 | 1994-08-30 | Sterling Winthrop Inc. | Polymeric X-ray compositions containing iodinated polymeric beads |
JPH08501097A (ja) * | 1992-09-04 | 1996-02-06 | ザ ゼネラル ホスピタル コーポレーション | 臨床診断及び治療用部分を含む生体適合性ポリマー |
US5871710A (en) * | 1992-09-04 | 1999-02-16 | The General Hospital Corporation | Graft co-polymer adducts of platinum (II) compounds |
US5340564A (en) * | 1992-12-10 | 1994-08-23 | Sterling Winthrop Inc. | Formulations comprising olin 10-G to prevent particle aggregation and increase stability |
US5336923A (en) * | 1992-12-31 | 1994-08-09 | Honeywell, Inc. | Varactor diode having a stepped capacitance-voltage profile |
US5342926A (en) * | 1993-06-08 | 1994-08-30 | The Regents Of The University Of California | Analogs of cytochalasin B as radiopharmaceuticals for nuclear imaging of trans-membrane glucose transport |
US5605672A (en) * | 1993-06-09 | 1997-02-25 | The General Hospital Corporation | Blood pool imaging composition and method of its use |
US6007845A (en) * | 1994-07-22 | 1999-12-28 | Massachusetts Institute Of Technology | Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers |
US20030119724A1 (en) * | 1995-11-22 | 2003-06-26 | Ts`O Paul O.P. | Ligands to enhance cellular uptake of biomolecules |
GB9705521D0 (en) | 1997-03-18 | 1997-05-07 | Univ Sheffield | The use of mononuclear phagocytes in the vivo imaging of hypoxic/ischaemic tissue |
DE19731591C2 (de) * | 1997-07-17 | 1999-09-16 | Schering Ag | Pharmazeutische Mittel enthaltend perfluoralkylgruppenhaltige Trijodaromaten und ihre Verwendung in der Tumortherapie und interventionellen Radiologie |
US6245316B1 (en) | 1997-10-08 | 2001-06-12 | David Platt | Enhancement of delivery of radioimaging and radioprotective agents |
US6093382A (en) | 1998-05-16 | 2000-07-25 | Bracco Research Usa Inc. | Metal complexes derivatized with folate for use in diagnostic and therapeutic applications |
US6723746B2 (en) | 1998-09-08 | 2004-04-20 | Veritas Pharmaceuticals, Inc. | Functional radiographic imaging methods and agents |
US6751290B2 (en) | 1998-09-08 | 2004-06-15 | Veritas Pharmaceuticals, Inc. | Radiographic assessment of tissue after exposure to a compound |
US6226352B1 (en) | 1998-09-08 | 2001-05-01 | Veritas Pharmaceuticals, Inc. | System and method for radiographic imaging of tissue |
US6426145B1 (en) | 1999-05-20 | 2002-07-30 | Scimed Life Systems, Inc. | Radiopaque compositions for visualization of medical devices |
FR2802817B1 (fr) * | 1999-12-23 | 2002-10-11 | Centre Nat Rech Scient | Nouveaux inhibiteurs de glycosidases et leurs applications pharmacologiques, notamment pour traiter le diabete |
US7169618B2 (en) * | 2000-06-28 | 2007-01-30 | Skold Technology | Magnetic particles and methods of producing coated magnetic particles |
WO2002043771A2 (en) | 2000-12-01 | 2002-06-06 | Cell Works Inc. | Conjugates of glycosylated/galactosylated peptide |
WO2002087629A1 (en) * | 2001-04-26 | 2002-11-07 | Analogic Corporation | Ct scanner for imaging a preselected portion of a patient |
WO2002100444A1 (en) * | 2001-06-08 | 2002-12-19 | Biosphere Medical Inc. | Colloidal metal labelled microparticles, their production and use |
US20050255176A1 (en) * | 2004-05-17 | 2005-11-17 | Burgess W P | Method for attenuating free radical formation resulting from bodily insult |
US7019035B2 (en) * | 2004-05-17 | 2006-03-28 | Md Scientific Llc | Method for attenuating free radical formation resulting from bodily insult |
US20050255175A1 (en) * | 2004-05-17 | 2005-11-17 | Burgess W P | Method for protecting nephron against injury caused by disruption of a chemical environment in the kidneys |
US7625586B2 (en) | 2004-10-28 | 2009-12-01 | Md Scientific, Llc | Method for mitigating injury to a kidney resulting from an ischemic event |
KR100695744B1 (ko) | 2005-05-03 | 2007-03-19 | 한국원자력연구소 | 디티피에이(dtpa) 유도체 및 이들을 이용한 금속 착화물, 이들을 포함하는 방사선원 및 조영제 |
CN1966088B (zh) * | 2006-11-16 | 2010-09-29 | 中国科学院长春应用化学研究所 | 阿拉伯半乳聚糖为载体的磁共振成像造影剂 |
AU2008353360A1 (en) * | 2008-03-24 | 2009-10-01 | The Board Of Regents Of The University Of Texas System | Image-guided therapy of myocardial disease: composition, manufacturing and applications |
JP2013502263A (ja) | 2009-08-18 | 2013-01-24 | ベン‐グリオン ユニバーシティ オブ ザ ネゲヴ リサーチ アンド デベロップメント オーソリティ | 撮像データを解析するためのシステムおよび方法 |
US9827265B1 (en) | 2012-04-06 | 2017-11-28 | Md Scientific, Llc | Method for attenuating free radical formation resulting from a bodily insult |
KR20160032000A (ko) * | 2013-03-15 | 2016-03-23 | 매튜 알. 드레허 | 이미지화 가능한 색전성 마이크로스피어 |
EP3506916B1 (en) | 2016-09-01 | 2021-04-07 | Chimera Bioengineering Inc. | Gold optimized car t-cells |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR6024559D0 (pt) * | 1959-12-08 | 1973-05-31 | Nyegaard & Co As | Processo para preparacao de novos derivados de acido 3 5-diamino-2 4 6-triiodo benzoico ou semi sais nao toxicos bem como de agentes ou meios de contraste para raios x baseados nos mesmos |
IT1053508B (it) * | 1970-07-06 | 1981-10-10 | Searle & Co | Procedimento per prepare composizioni marcate adatte a mettere in evidenza alterazioni della mucosa gastrointestinale prodotto ottenuto e relativo metodo di impiego |
US4069306A (en) * | 1974-03-14 | 1978-01-17 | Pharmacia Aktiebolag | X-ray contrast preparation containing a hydrophilic polymer containing amino groups |
US4038379A (en) * | 1976-03-24 | 1977-07-26 | Nikolai Petrovich Elinov | Composition for roentgenoscopy of the gastrointestinal tract containing a polysaccharide stabilizer |
US4243653A (en) * | 1979-04-27 | 1981-01-06 | The Regents Of The University Of California | Non-ionic polyiodo sugar substituted anilines |
US4431626A (en) * | 1981-05-27 | 1984-02-14 | The Regents Of The University Of California | Tc-99m Labeled carrier for imaging |
US4501726A (en) * | 1981-11-12 | 1985-02-26 | Schroeder Ulf | Intravascularly administrable, magnetically responsive nanosphere or nanoparticle, a process for the production thereof, and the use thereof |
US4396598A (en) * | 1982-01-11 | 1983-08-02 | Mallinckrodt, Inc. | Triiodoisophthalamide X-ray contrast agent |
FR2550449B1 (fr) * | 1983-08-12 | 1986-01-31 | Commissariat Energie Atomique | Agents de relaxation specifiques d'organes ou de pathologies, utilisables pour modifier les contrastes en imagerie medicale par resonance magnetique nucleaire |
CA1224003A (en) * | 1984-04-24 | 1987-07-14 | Robert S. Molday | Colloidal sized metal-polysaccharide particles |
US4542225A (en) * | 1984-08-29 | 1985-09-17 | Dana-Farber Cancer Institute, Inc. | Acid-cleavable compound |
SE465907B (sv) * | 1984-11-01 | 1991-11-18 | Nyegaard & Co As | Diagnosticeringsmedel innehaallande en paramagnetisk metall |
US4675173A (en) * | 1985-05-08 | 1987-06-23 | Molecular Biosystems, Inc. | Method of magnetic resonance imaging of the liver and spleen |
US4827945A (en) * | 1986-07-03 | 1989-05-09 | Advanced Magnetics, Incorporated | Biologically degradable superparamagnetic materials for use in clinical applications |
US4770183A (en) * | 1986-07-03 | 1988-09-13 | Advanced Magnetics Incorporated | Biologically degradable superparamagnetic particles for use as nuclear magnetic resonance imaging agents |
US4822594A (en) * | 1987-01-27 | 1989-04-18 | Gibby Wendell A | Contrast enhancing agents for magnetic resonance images |
US4859449A (en) * | 1987-09-14 | 1989-08-22 | Center For Molecular Medicine And Immunology | Modified antibodies for enhanced hepatocyte clearance |
EP0670167A1 (en) * | 1988-08-04 | 1995-09-06 | Advanced Magnetics Incorporated | Receptor mediated endocytosis type diagnostic agents |
WO1990001900A1 (en) * | 1988-08-24 | 1990-03-08 | The University Of Connecticut | Carrier system and method for enhancement of magnetic resonance imaging |
EP0361960A3 (en) * | 1988-09-29 | 1992-01-02 | RANNEY, David F. | Methods and compositions for magnetic resonance imaging |
US5066789A (en) * | 1988-09-30 | 1991-11-19 | Neorx Corporation | Targeting substance-diagnostic/therapeutic agent conjugates having Schiff base linkages |
GB8919929D0 (en) * | 1989-09-04 | 1989-10-18 | Nycomed As | Compositions |
-
1991
- 1991-04-02 US US07/679,526 patent/US5141739A/en not_active Expired - Fee Related
-
1992
- 1992-03-18 CA CA002105068A patent/CA2105068A1/en not_active Abandoned
- 1992-03-18 EP EP92910570A patent/EP0578765A1/en not_active Ceased
- 1992-03-18 ES ES92910570T patent/ES2061423T1/es active Pending
- 1992-03-18 WO PCT/US1992/002255 patent/WO1992017216A1/en not_active Application Discontinuation
- 1992-03-18 JP JP4509688A patent/JPH06506230A/ja active Pending
- 1992-03-18 DE DE0578765T patent/DE578765T1/de active Pending
-
1994
- 1994-04-29 GR GR940300022T patent/GR940300022T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0578765A1 (en) | 1994-01-19 |
WO1992017216A1 (en) | 1992-10-15 |
US5141739A (en) | 1992-08-25 |
CA2105068A1 (en) | 1992-10-03 |
JPH06506230A (ja) | 1994-07-14 |
ES2061423T1 (es) | 1994-12-16 |
DE578765T1 (de) | 1994-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR940300022T1 (en) | Delivery of x-ray contrast agents using receptor mediated endocytosis. | |
GR3036937T3 (en) | Pharmaceutical formulations. | |
GB2262138B (en) | Single dose dispenser | |
GR3018890T3 (en) | Medicament dispensing device. | |
ZA926020B (en) | Pharmaceutical combination formulation. | |
NZ242061A (en) | Inhaler for powdered medicament | |
PH31205A (en) | Pharmaceutical composition. | |
HU9303728D0 (en) | Inhaler for powdered medical agents | |
ZA925275B (en) | Cosmetic delivery system | |
EP0605442A4 (en) | RECOMBINANT ANTIBODIES FOR HUMAN THERAPY. | |
IL103621A0 (en) | Endothelin receptor antagonists and pharmaceutical compositions containing them | |
ZA927562B (en) | Medicament. | |
ZA925276B (en) | Cosmetic delivery system | |
EP0601058A4 (en) | TRANSDERMAL FORMULATIONS FOR PRRAZOSINE ADMINISTRATION. | |
ZA927384B (en) | Dual rate agent delivery device | |
OA09810A (en) | Pharmaceutical composition. | |
EP0613445A4 (en) | DISTRIBUTOR. | |
EP0497169A3 (en) | X-ray line | |
IL101010A0 (en) | Steroid pharmaceutical formulations | |
GB9026606D0 (en) | Dose dispenser | |
GB9103302D0 (en) | Pharmaceutical formulations | |
GB9121463D0 (en) | Medicament | |
ZA92110B (en) | Pharmaceutical compositions. | |
ZA927369B (en) | Pharmaceutical compositions. | |
GB2253637B (en) | Button delivery apparatus |